Bio-Rad Laboratories Competitive Intelligence & Landscape
bio-rad.com ·
Overview
Bio-Rad Laboratories Overview
Founded in 1952 [https://www.bio-rad.com/en-us/about/our-history?ID=1757378124555], Bio-Rad Laboratories is headquartered in Hercules, California, USA, specifically at 1000 Alfred Nobel Drive [https://www.bio-rad.com/en-us/help-center/contact-information]. The company serves a diverse target market, including universities, research institutions, hospitals, public health and commercial laboratories, food safety and environmental quality laboratories, and biopharmaceutical companies [https://www.bio-rad.com/en-uk/corporate/about-bio-rad?ID=1003].
Bio-Rad Laboratories offers a comprehensive range of products, including consumables, reagents, and instruments designed to advance research and ensure accuracy in diagnostics [https://www.bio-rad.com/en-us/p]. Their offerings span various areas such as antibodies and electrophoresis systems, supporting efforts in novel therapeutics, medical device development, and environmental understanding [https://www.bio-rad.com/en-us/p]. The company emphasizes quality and customer service, working to empower scientists and clinicians to improve lives through science [https://www.bio-rad.com/en-us/about/about-us?ID=1756930869883].
Sources
Investor Relations: Bio-Rad Laboratories, Inc.
investors.bio-rad.com
Bio-Rad Laboratories
bio-rad.com
About Us | Bio-Rad
bio-rad.com
Our History | Bio-Rad
bio-rad.com
Contact Information | Bio-Rad
bio-rad.com
Leading Life Science Research & Clinical Diagnostics | Bio-Rad
bio-rad.com
319183___CLEANLPDF_LAN_15Mar202418570257_010.PDF
bio-rad.com
About Bio-Rad
bio-rad.com
Products - Bio-Rad
bio-rad.com
Bio-Rad Careers
careers.bio-rad.com
Bio-Rad Laboratories Weekly Intel Updates
Receive weekly intel updates about Bio-Rad Laboratories straight to your inbox.
Competitors
Bio-Rad Laboratories Competitors
Agilent Technologies stands as another significant competitor, particularly in areas involving laboratory technologies for analysis and characterization, as well as life sciences. Agilent's focus on analytical instrumentation and diagnostics solutions directly overlaps with many of Bio-Rad's offerings. While both companies vie for market share, Agilent is often highlighted for its strong customer satisfaction and product quality, positioning it as a strong alternative in the industry [https://www.comparably.com/companies/bio-rad-laboratories/competitors].
Roche, a global healthcare company, also competes with Bio-Rad, especially in the clinical diagnostics and life science research segments. Roche’s key differentiators include its extensive diagnostics portfolio, including in-vitro diagnostics and personalized healthcare solutions. Its market positioning as a leader in medical diagnostics means it competes with Bio-Rad on a global scale, particularly in areas like PCR systems and immunoassay products [https://www.owler.com/company/bio-rad/competitors].
Beckman Coulter Diagnostics is another prominent competitor, specializing in products for biomedical testing. This company develops, manufactures, and markets a wide array of products for clinical diagnostics and life science research, directly competing with Bio-Rad's diagnostic offerings. Beckman Coulter's competitive edge often lies in its integrated systems and automation solutions for laboratories, providing a strong alternative for customers seeking comprehensive diagnostic platforms [https://craft.co/bio-rad/competitors].
Finally, Danaher Corporation represents an indirect competitor, being a diversified global science and technology innovator that includes several operating companies in the life sciences and diagnostics sectors. While Danaher itself is a larger conglomerate, its various subsidiaries compete with Bio-Rad in specific niches. Danaher's broad market presence and continuous innovation across its portfolio allow it to maintain significant market share and offer a range of solutions that may indirectly compete with Bio-Rad's specialized products [https://koalagains.com/stocks/NYSE/BIO/competition].
Sources
Bio-Rad Laboratories Inc Peers & Key Competitors - GlobalData
globaldata.com
Top Bio-Rad Alternatives, Competitors - CB Insights
cbinsights.com
Top Bio-Rad Laboratories (BIO) Competitors 2026 - MarketBeat
marketbeat.com
Bio-Rad's Competitors, Revenue, Number of Employees ... - Owler
owler.com
Bio-Rad - Overview, News & Similar companies | ZoomInfo.com
zoominfo.com
Bio Rad - 2026 Company Profile & Team - Tracxn
tracxn.com
Bio-Rad Competitors and Alternatives - Owler
owler.com
Bio-Rad Laboratories Competitors | Comparably
comparably.com
Top Bio-Rad Competitors and Alternatives | Craft.co
craft.co
Bio-Rad Laboratories, Inc. (BIO) Competitive Analysis & Comparison (2026)
koalagains.com
Product & Pricing
Bio-Rad Laboratories Product and Pricing Intelligence
Bio-Rad Laboratories provides a range of Real-Time PCR Systems, such as the CFX Opus 96 Real-Time PCR System and the CFX Opus 384 Real-Time PCR System [https://www.bio-rad.com/en-us/category/real-time-pcr-systems?ID=059db09c-88a4-44ad-99f8-78635d8d54db]. The CFX Opus 384, for instance, is a 384-well, 4-color plus FRET, network-connected real-time PCR detection system [https://www.bio-rad.com/en-us/sku/12011452-cfx-opus-384-real-time-pcr-system?ID=12011452]. For detailed pricing information on these systems, customers are generally advised to contact their local Bio-Rad representative [https://www.bio-rad.com/sites/default/files/2023-04/Bulletin_7479.pdf]. The company also offers the QX700 HT Droplet Digital PCR System, which facilitates 7-color multiplexing for up to 384 samples per run and includes associated software [https://www.bio-rad.com/en-us/product/qx700-ht-droplet-digital-pcr-system?ID=4d7ba87f-1141-00ab-a440-0ed5cd2e4451].
For new laboratories or those with new grants, Bio-Rad Laboratories offers a "Transformative New Lab & New Grant Program" designed to provide tailored packages of laboratory reagents and instrumentation. This program supports a wide range of applications including digital, real-time, and conventional PCR, western blotting, cell biology, and protein purification, offering customized solutions to fit specific needs [https://www.bio-rad.com/en-us/services/new-labs-new-grants].
Customers can benefit from several free and paid features through a My Bio-Rad account. Free features include online ordering, batch number requests, standing orders, shipment tracking, and downloadable invoices. A key paid or account-specific feature is account-specific pricing, which suggests that pricing may vary based on customer agreements or volume [https://www.bio-rad.com/en-us/feature/my-bio-rad-account-advantages.html].
Sources
MyBio-Rad Account Advantages | Bio-Rad
bio-rad.com
PrimePCR™ PCR Primers, Assays, and Arrays | Bio-Rad
bio-rad.com
Real-Time PCR Systems — Bio-Rad
bio-rad.com
[PDF] Life Science Research - 2023 - Bio-Rad
bio-rad.com
CFX Opus 384 Real-Time PCR System #12011452 | Bio-Rad
bio-rad.com
New Labs & New Grants | Bio-Rad
bio-rad.com
Leukemia - Myeloid Pathway Map - PrimePCR | Life Science | Bio-Rad
commerce.bio-rad.com
Droplet Digital PCR (ddPCR) Enhancer Reagent A #12013425
bio-rad.com
iScript cDNA Synthesis Kits | Bio-Rad
bio-rad.com
QX700™ HT Droplet Digital™ PCR System | Bio-Rad
bio-rad.com
Ad Campaigns
Bio-Rad Laboratories Ad Campaigns
See the live ads Bio-Rad Laboratories is running across Google, Meta, and LinkedIn — the creative, messaging, and platforms behind every campaign, updated automatically by ForesightIQ.
See of Bio-Rad Laboratories's ads
Browse the live creative across Google, Meta & LinkedIn in the ad library
Hiring & Layoffs
Bio-Rad Laboratories Hiring and Layoffs
Bio-Rad Laboratories (bio-rad.com) currently lists numerous job openings across various departments and locations. Notable job openings include Quality Control Technician II, Sr. Director of Innovation and Project Management, and Software Developer IV careers.bio-rad.com/jobs/search. Other positions like Field Application Scientist and Sr. Manager, R&D Portfolio Finance and Analytics, further highlight the breadth of their hiring needs careers.bio-rad.com/jobs/field-application-scientist-california-united-states [careers.bio-rad.com/jobs/sr-manager-r-d-portfolio-finance-and-analytics-hercules-california-united-states-0cd2e981-774a-46eb-b045-6c43f4f6f9e0]. These roles span critical areas such as Research & Development, Sales & Service, Finance, and Manufacturing/Production, indicating robust activity across their core business functions careers.bio-rad.com/global-job-categories.
The company's hiring patterns signal a strategic focus on strengthening its scientific and diagnostic capabilities, as evidenced by roles in innovation, research, and quality control. The availability of both onsite and hybrid work types, in locations such as Hercules, CA (their corporate headquarters), and Irvine, CA, suggests flexibility and a commitment to attracting talent in key operational hubs careers.bio-rad.com/hercules careers.bio-rad.com/irvine careers.bio-rad.com/jobs/software-developer-iv-ref-116-1020-7-irvine-california-united-states. This ongoing recruitment drive reinforces Bio-Rad Laboratories' (bio-rad.com) commitment to advancing science and patient care, as stated in their mission to "Powering Possibilities. Saving Lives Together" bio-rad.com.
Sources
Search - Jobs near me - Bio-Rad Careers
careers.bio-rad.com
Bio-Rad Careers
careers.bio-rad.com
US Landing Page - Bio-Rad Careers
careers.bio-rad.com
Global Job Categories - Bio-Rad Careers
careers.bio-rad.com
Bio-Rad Laboratories
bio-rad.com
Hercules - Bio-Rad Careers
careers.bio-rad.com
Irvine - Bio-Rad Careers
careers.bio-rad.com
Software Developer IV (Ref: 116.1020.7) - Irvine, California, United States
careers.bio-rad.com
Sr. Manager, R&D Portfolio Finance and Analytics - Hercules, California, United States
careers.bio-rad.com
Field Application Scientist - California, United States
careers.bio-rad.com
Leadership
Bio-Rad Laboratories Management and Leadership Team
Recent leadership changes at Bio-Rad Laboratories include several key appointments. Jon DiVincenzo was named President and Chief Operating Officer, effective September 9, 2024, succeeding Andy Last [https://investors.bio-rad.com/press-releases/news-details/2024/Bio-Rad-Appoints-Jon-DiVincenzo-President-Chief-Operating-Officer/default.aspx]. Roop K. Lakkaraju joined the company as the new Executive Vice President and Chief Financial Officer [https://investors.bio-rad.com/press-releases/news-details/2024/Bio-Rad-Appoints-Roop-K.-Lakkaraju-Executive-Vice-President-Chief-Financial-Officer/default.aspx]. Additionally, Anette Engelhardt was appointed Executive Vice President and President of the Clinical Diagnostics Group, effective June 10, 2024 [https://investors.bio-rad.com/press-releases/news-details/2024/Bio-Rad-Names-Anette-Engelhardt-Executive-Vice-President-and-President-of-Clinical-Diagnostics-Group/default.aspx].
Further C-suite and leadership team appointments include Rajat Mehta as Executive Vice President, Global Commercial Operations [https://investors.bio-rad.com/press-releases/news-details/2025/Bio-Rad-Appoints-Rajat-Mehta-Executive-Vice-President-Global-Commercial-Operations/default.aspx]. The company also announced management changes within its Life Science Group, with Barry assuming the role of Executive Vice President and President of the Life Science Group [https://investors.bio-rad.com/press-releases/news-details/2024/Bio-Rad-Announces-Life-Science-Group-Management-Changes/default.aspx].
The board of directors at Bio-Rad Laboratories includes experienced professionals such as Jeffrey L. Edwards, former EVP and CFO of Allergan, Inc.; Gregory K. Hinckley, former President of Mentor Graphics Corporation; Melinda Litherland, retired Partner at Deloitte & Touche LLP; and Arnold A. Pinkston, Corporate Vice President and General Counsel of Edwards Lifesciences Corporation. Allison Schwartz also serves as Commercial Director of Bio-Rad Laboratories (Canada) Limited [https://www.bio-rad.com/webroot/web/pdf/corporate/literature/Bio-Rad-Proxy-Statement-2024.pdf].
Sources
Corporate Officers - Bio-Rad
bio-rad.com
About Us | Bio-Rad
bio-rad.com
HD-export
bio-rad.com
bio-rad.com
Bio-Rad Laboratories, Inc. - Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer
investors.bio-rad.com
Corporate Officers | Bio-Rad
bio-rad.com
Bio-Rad Appoints Rajat Mehta Executive Vice President, Global ...
investors.bio-rad.com
Bio-Rad Names Anette Engelhardt Executive Vice President and ...
investors.bio-rad.com
Bio-Rad Laboratories, Inc. - Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
investors.bio-rad.com
Bio-Rad Announces Life Science Group Management Changes
investors.bio-rad.com
Financials
Bio-Rad Laboratories Financial Performance, Fundraising, M&A
Sources
Bio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial Results
investors.bio-rad.com
Investor Relations: Bio-Rad Laboratories, Inc.
investors.bio-rad.com
Bio-Rad Laboratories, Inc. - Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results
investors.bio-rad.com
[PDF] FORM 10-K For the year ended December 31, 2021 Commission file ...
bio-rad.com
Bio-Rad Laboratories, Inc. - Bio-Rad Reports First-Quarter 2026 Financial Results
investors.bio-rad.com
Bio-Rad Laboratories, Inc. - Financials - Financial Results
investors.bio-rad.com
319183___CLEANLPDF_LAN_15Mar202418570257_010.PDF
bio-rad.com
Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
investors.bio-rad.com
[PDF] BIO-RAD LABORATORIES, INC.
bio-rad.com
Bio-Rad Laboratories, Inc. - Bio-Rad Reports Second-Quarter 2025 Financial Results
investors.bio-rad.com
Partnerships
Bio-Rad Laboratories Partnerships, Clients and Vendors
Bio-Rad Laboratories also engages in crucial alliances within the clinical diagnostics sector. They have expanded their joint marketing agreement with Siemens Healthineers, supplying quality control products and Unity Quality Control data management solutions [3]. Furthermore, Bio-Rad has broadened its partnership with a major diagnostics company to deliver InteliQ portfolio quality controls [5] and has specifically expanded its independent quality control products, including InteliQ and Liquichek compact vials, for the Abbott Alinity ci-series instruments [7]. Another significant collaboration involves Seegene, a global leader in multiplex molecular diagnostics, for the clinical development and commercialization of molecular diagnostic testing products [10].
In terms of technology integration and strategic licensing, Bio-Rad has entered an exclusive licensing agreement with NuProbe USA for its allele enrichment technologies, which will be used in the development of multiplexed digital PCR assays [4]. They also collaborate with Allegheny Health Network (AHN) in a research collaboration aimed at generating clinical evidence for implementing Bio-Rad’s Droplet Digital™ PCR (ddPCR™) technology for tumor-informed molecular monitoring [8]. For data analysis, Bio-Rad offers exclusive availability of Biogazelle's qbasePLUSqPCR data analysis software for their CFX96 and CFX384 real-time PCR detection systems [9]. Additionally, Bio-Rad has partnered with ADInstruments and Vernier Software to integrate Bio-Rad Explorer classroom laboratory activities with Lt, an online learning platform [6].
Sources
Bio-Rad Extends Partnership with Gencurix Through Strategic Agreement for Droplet Digital™ PCR IVD Oncology Kits in Europe | Bio-Rad
bio-rad.com
Bio-Rad and Element Biosciences Partner to Deliver Seamless RNA Sequencing Workflow Between Element’s AVITI™ System and Bio-Rad’s SEQuoia™ Express and SEQuoia™ Complete Stranded RNA Library Prep Kits | Bio-Rad
bio-rad.com
Bio-Rad Expands Joint Marketing Agreement with Siemens Healthineers, Providing Quality Controls to Optimize Efficiency and Data Reliability | Bio-Rad
bio-rad.com
Bio-Rad and NuProbe Enter into an Exclusive Licensing Agreement for Digital PCR Applications | Bio-Rad
bio-rad.com
Bio-Rad Expands Partnership with a Major Diagnostics Company to Provide InteliQ Portfolio Quality Controls | Bio-Rad
bio-rad.com
Bio-Rad Partners with ADInstruments to Integrate Bio-Rad Explorer Classroom Laboratory Activities with Lt, the Award-Winning Online Learning Platform | Bio-Rad
bio-rad.com
Bio-Rad Laboratories, Inc. - Bio-Rad Expands Range of Quality Controls for Abbott Clinical Diagnostics Platforms
investors.bio-rad.com
Bio-Rad and Allegheny Health Network Cancer Institute Partner to Advance Personalized Monitoring of Solid Tumor Cancers with Droplet Digital PCR | Bio-Rad
bio-rad.com
Bio-Rad Announces the Exclusive Availability of Biogazelle's qbase PLUS Data Analysis Software with Bio-Rad's CFX96™ and CFX384™ Real-Time PCR Systems
bio-rad.com
Bio-Rad Laboratories, Inc. - Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products
investors.bio-rad.com
Events
Bio-Rad Laboratories Event Participations
Bio-Rad frequently organizes webinars covering a broad spectrum of topics. These include both upcoming and on-demand sessions, such as discussions on ddPCR technology applications for rare mutation detection and gene expression, and tumor-informed ctDNA analysis [bio-rad.com/en-us/r/web]. The company's "Life Science Webinars" section offers featured series like "Coffee Chat with Bio-Rad Application Scientists" for customer Q&A, and "Blot Talk: Monthly Live Webinar Series" [bio-rad.com/en-us/life-science-research/support/webinars?ID=KVY63C4VY]. Clinical diagnostics webinars address subjects like immunohematology, including antibody identification and warm AIHA, and infectious disease testing [bio-rad.com/en-us/clinical-diagnostics/support/webinars?ID=1631574160938].
Key annual events for Bio-Rad include ddPCR World, which is described as their premier global digital PCR event series, bringing together scientists, researchers, and industry leaders through in-person and online formats [bio-rad.com/en-us/life-science-research/support/webinars/droplet-digital-pcr-world-2026?ID=1779295136574]. In 2026, ddPCR World On Tour will feature a European leg, offering a full day of expert sessions, applied demos, and peer connections at local venues for digital PCR and qPCR scientists [info.bio-rad.com/droplet-digital-pcr-world-on-tour-emea-2026.html?WT.mc_id=260410051485]. Additionally, Bio-Rad is scheduled to participate in Future Labs 2026 [bio-rad.com/en-us/life-science-research/events/future-labs-2026?ID=Future-Labs-2026_1777407167].
For process separations, Bio-Rad lists events focusing on bioprocess chromatography. These include sessions on optimizing antibody-drug conjugate (ADC) purification strategies and participation in conferences like the Bioprocessing Summit Europe and ACS BIOT [bio-rad.com/en-us/process-separations/events]. The company also offers hands-on courses, such as an "Introduction to Preparative Chromatography," in collaboration with institutions like DTU Biotech Lifelong Learning [bio-rad.com/en-nl/nws/ee].
Sources
Events | Bio-Rad
bio-rad.com
Webinars — Bio-Rad
bio-rad.com
Life Science Events | Bio-Rad
bio-rad.com
Life Science Webinars | Bio-Rad
bio-rad.com
Future Labs 2026 | Bio-Rad
bio-rad.com
Droplet Digital™ PCR World 2026 - Bio-Rad
bio-rad.com
Bioprocess Chromatography Events | Bio-Rad
bio-rad.com
Clinical Diagnostics Webinars
bio-rad.com
Droplet Digital PCR World 2026 On Tour - A global gathering of users, thought leaders, and visionaries
info.bio-rad.com
Events | Bio-Rad
bio-rad.com
Frequently Asked Questions
What strategic implications arise from Bio-Rad Laboratories' extensive event participation, particularly ddPCR World?
Bio-Rad Laboratories' frequent participation in and hosting of diverse events, including ddPCR World, suggests a strong strategic focus on market education, thought leadership, and direct engagement with the scientific community. ddPCR World, described as their premier global digital PCR event, highlights their commitment to showcasing and advancing their proprietary ddPCR technology, crucial for rare mutation detection and gene expression, aiming to solidify its position as an industry standard.
What can be inferred about Bio-Rad Laboratories' current growth strategy based on its hiring activity?
Bio-Rad Laboratories' strong hiring initiative, evidenced by numerous job openings across Research & Development, Sales & Service, Finance, and Manufacturing/Production, signals a strategic focus on growth and expansion. Key roles like Sr. Director of Innovation and Project Management, and Software Developer IV indicate an emphasis on strengthening scientific capabilities and product development, while Field Application Scientist roles suggest an expansion of market reach and customer support.
What is the strategic significance of Bio-Rad Laboratories' recent leadership changes, including the appointment of Jon DiVincenzo as President and COO?
The recent executive appointments at Bio-Rad Laboratories, including Jon DiVincenzo as President and COO, Roop K. Lakkaraju as EVP and CFO, and Anette Engelhardt as EVP and President of the Clinical Diagnostics Group, indicate a strategic re-alignment or reinforcement of leadership across key operational and commercial functions. These changes suggest a focus on driving progress in specific areas like biopharma, bioprocessing, and molecular diagnostics, aiming for sustained innovation and operational excellence.
How does Bio-Rad Laboratories' reported 2024 revenue compare to 2023, and what does this suggest about its market performance?
Bio-Rad Laboratories reported full-year 2024 revenue of $2,566.5 million, a decrease from its 2023 full-year revenue of $2,671 million. This suggests a slight contraction in overall revenue year-over-year, indicating potential market headwinds or shifts in demand within its life science research and clinical diagnostics markets.
What is the competitive positioning of Bio-Rad Laboratories relative to Thermo Fisher Scientific and Agilent Technologies?
Bio-Rad Laboratories faces strong competition from Thermo Fisher Scientific, which has a broad portfolio and extensive market share, and Agilent Technologies, known for analytical instrumentation and customer satisfaction. While Bio-Rad competes across similar product categories like reagents and instruments, Thermo Fisher often challenges on breadth and integrated solutions, and Agilent on product quality and analytical focus.
How does Bio-Rad Laboratories differentiate itself from alternatives like QIAGEN and Hologic?
Bio-Rad Laboratories differentiates itself from QIAGEN by offering a broader portfolio beyond QIAGEN's 'Sample to Insight' focus on molecular insights and sample preparation. Against Hologic, Bio-Rad maintains a more generalized life science and clinical diagnostics approach, while Hologic specializes in women's health diagnostics and related surgical/medical aesthetic products.
What is the strategic rationale behind Bio-Rad Laboratories' expanded partnership with Siemens Healthineers for quality control products?
Bio-Rad Laboratories' expanded joint marketing agreement with Siemens Healthineers for quality control products and Unity Quality Control data management solutions indicates a strategy to strengthen its position in clinical diagnostics. This partnership leverages Siemens Healthineers' market reach to integrate Bio-Rad's quality control solutions more broadly, potentially increasing market penetration and standardizing quality assurance practices across more diagnostic platforms.
What is the significance of Bio-Rad Laboratories' exclusive licensing agreement with NuProbe USA for allele enrichment technologies?
Bio-Rad Laboratories' exclusive licensing agreement with NuProbe USA for allele enrichment technologies is significant for enhancing its multiplexed digital PCR assay development. This partnership allows Bio-Rad to integrate advanced technologies that can improve the sensitivity and specificity of its ddPCR assays, particularly for applications requiring the detection of rare alleles, which aligns with their focus on innovation in molecular diagnostics.
How does Bio-Rad Laboratories' 'Transformative New Lab & New Grant Program' contribute to its market strategy?
The 'Transformative New Lab & New Grant Program' is a strategic initiative by Bio-Rad Laboratories to establish early relationships with new or expanding laboratories. By offering tailored packages of reagents and instrumentation, including for digital PCR, real-time PCR, and western blotting, the program aims to embed Bio-Rad's ecosystem into emerging research and diagnostic workflows, fostering long-term customer loyalty and market share.
What does the availability of account-specific pricing for My Bio-Rad account holders suggest about their sales strategy?
The availability of account-specific pricing for My Bio-Rad account holders indicates a flexible and personalized sales strategy, likely designed to cater to varying customer segments, purchase volumes, and long-term agreements. This approach allows Bio-Rad to optimize pricing for different institutional sizes or research needs, potentially fostering stronger customer relationships and incentivizing bulk or recurring purchases.
Powered by ForesightIQ · Competitive intelligence from digital exhaust